Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 93 Graham Number is $36.53 as of Feb. 2026, which is 1803% above its 10-year median of 1.92. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $50.48 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 368 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks better than 69.29% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
The historical rank and industry rank for COSMOS Pharmaceutical's Graham Number or its related term are showing as below:
CSMYF'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.14 Med: 1.92 Max: 2.69
Current: 1.14
During the past 13 years, the highest Price to Graham Number ratio of COSMOS Pharmaceutical was 2.69. The lowest was 1.14. And the median was 1.92.
CSMYF's Price-to-Graham-Number is ranked better than 69.29% of 368
companies
in the Healthcare Providers & Services industry
Industry Median: 1.69
vs CSMYF: 1.14
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
COSMOS Pharmaceutical (OTCPK:CSMYF) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
COSMOS Pharmaceutical's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Feb. 2026 )
=
37.06
/
36.41
=
1.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
COSMOS Pharmaceutical Graham Number Related Terms
COSMOS Pharmaceutical Graham Number Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Graham Number can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Graham Number Competitor Comparison
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Price-to-Graham-Number vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical (CSMYF) has a Graham Number of $36.53 as of Feb. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on COSMOS Pharmaceutical and its competitors. This is 1803% above median its historical median of 1.92. Over the past decade, COSMOS Pharmaceutical's Graham Number has ranged from 1.14 to 2.69. According to the industry distribution chart, COSMOS Pharmaceutical ranks #113 out of 368 companies in the Healthcare Providers & Services industry, placing it in the top 30.7%.
Is COSMOS Pharmaceutical's Graham Number too high?
COSMOS Pharmaceutical's current Graham Number of $36.53 is 1803% above median its 10-year median of 1.92. Over the past 10 years, this metric has ranged from a low of 1.14 to a high of 2.69. The Healthcare Providers & Services industry median Graham Number is 1.69. COSMOS Pharmaceutical's value of $36.53 is 2061.5% above this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #113 out of 368 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Graham Number compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #113 out of 368 companies for Graham Number. This puts COSMOS Pharmaceutical in the upper half of its industry. The industry median Graham Number is 1.69. COSMOS Pharmaceutical's value of $36.53 is 2061.5% above this benchmark. Historically, COSMOS Pharmaceutical's own Graham Number has ranged from 1.14 to 2.69 over the past decade. While the company's 10-year median is 1.92 vs. the industry median of 1.69, COSMOS Pharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Healthcare Providers & Services company?
The median Graham Number among Healthcare Providers & Services companies is 1.69, based on 368 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Graham Number of $36.53 is 2061.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Graham Number is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Graham Number is $36.53, which is 1803% above median its own 10-year median of 1.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $50.48, compared to a current price of $37.06 — trading 26.6% below its estimated fair value. The current Graham Number is $36.53, which is 1803% above median its 10-year median of 1.92 and 2061.5% above the Healthcare Providers & Services industry median of 1.69. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Graham Number is $36.53 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Graham Number: $36.53 (1803% above median its 10-year median of 1.92)
GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
Industry Position: 2061.5% above the Healthcare Providers & Services median (#113 of 368)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score
Get the complete analysis for CSMYF
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
